id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0655-0016,FDA,FDA-2011-N-0655,Agency Information Collection Activities; Proposed Collection; Comment Request; Animal Generic Drug User Fee Act Cover Sheet,Notice,60 Day Proposed Information Collection,2016-09-02T04:00:00Z,2016,9,2016-09-02T04:00:00Z,2016-11-02T03:59:59Z,2016-09-02T13:31:43Z,2016-21177,0,0,09000064821c12e4
FDA-2011-N-0655-0012,FDA,FDA-2011-N-0655,ANIMAL GENERIC DRUG USER FEE ACT PUBLIC MEETING,Other,Hearing/Meeting Transcript,2016-06-21T04:00:00Z,2016,6,2016-06-21T04:00:00Z,,2016-06-21T17:04:15Z,,0,0,0900006482054a1d
FDA-2011-N-0655-0010,FDA,FDA-2011-N-0655,Animal Generic Drug User Fee Act; Public Meeting; Request for Comments,Notice,Meeting,2016-04-20T04:00:00Z,2016,4,2016-04-20T04:00:00Z,2017-12-02T04:59:59Z,2017-11-24T02:04:00Z,2016-09150,0,0,0900006481f77f1f
FDA-2011-N-0655-0011,FDA,FDA-2011-N-0655,"Animal Generic Drug User Fee Act; Stakeholder Consultation Meetings on the Animal Generic Drug User Fee Act Reauthorization; Request for
Notification of Stakeholder Intention To Participate",Notice,Meeting,2016-04-20T04:00:00Z,2016,4,2016-04-20T04:00:00Z,2017-12-02T04:59:59Z,2016-06-20T01:00:28Z,2016-09152,0,0,0900006481f77fc1